Serum heparan sulfate levels are elevated in endotoxemia.

Area of Science:

• Vascular physiology
• Sepsis research
• Biomarker discovery

Background:

• Sepsis-induced vascular permeability was historically attributed solely to endothelial cell dysfunction.
• The endothelial glycocalyx plays a critical role in maintaining vascular barrier integrity and regulating inflammation.
• Heparan sulfate in blood indicates damage or shedding of the endothelial glycocalyx.

Purpose of the Study:

• To investigate if endotoxin administration causes endothelial glycocalyx shedding, indicated by elevated serum heparan sulfate.
• To assess changes in inflammatory markers following endotoxin exposure.

Main Methods:

• Administered endotoxin from Escherichia coli to 15 pigs.
• Monitored serum heparan sulfate levels over 6 hours.
• Evaluated inflammatory markers: white blood cell count, platelet count, tumor necrosis factor-α, and interleukin-6.

Main Results:

• Serum heparan sulfate concentrations significantly increased over time in the endotoxin group.
• Heparan sulfate levels were significantly higher in the endotoxin group compared to controls at 6 hours (p<0.001).
• All measured inflammatory markers showed significant changes in the endotoxin group.

Conclusions:

• Bacterial endotoxin administration leads to a significant increase in endothelial glycocalyx degradation products.
• This finding supports the role of the endothelial glycocalyx in sepsis-related vascular changes.